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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYOne of the major components of the subventricular zone (SVZ) neurogenic niche is the specialized vasculature. The SVZ vasculature
is thought to be important in regulating progenitor cell proliferation and migration. Epidermal growth factor (EGF) is a mitogen
with a wide range of effects. When stem and progenitor cells in the rat SVZ are treated with EGF, using intracerebroventricular
infusion, dysplastic polyps are formed. Upon extended infusion, blood vessels are recruited into the polyps. In the current study we
demonstrate how polyps develop through distinct stages leading up to angiogenesis. As polyps progress, microglia/macrophages
accumulate in the polyp core concurrent with increasing cell death. Both microglia/macrophage accumulation and cell death peak
during angiogenesis and subsequently decline following polyp vascularization. This model of inducible angiogenesis in the SVZ neuro-
genic niche suggests involvement of microglia/macrophages in acquired angiogenesis and can be used in detail to study angiogenesis
in the adult brain.INTRODUCTION
The subventricular zone (SVZ) of the lateral ventricle walls
is one of the main germinal zones in the adult mammalian
brain (Altman, 1969). Adult neurogenesis within the SVZ
proceeds via a well-defined sequence of events. Slowly
dividing stem cells, so-called B cells, give rise to rapidly
proliferating transient amplifying C-cells. Neuroblasts are
generated from these proliferating progenitors andmigrate
to the olfactory bulb, where they differentiate into inter-
neurons (Luskin, 1993; Doetsch et al., 1997).
The environment provided by the cells in the SVZ is
very different from that of the surrounding nonneuro-
genic regions. The unique proneurogenic conditions in
the SVZ make up what is called the neurogenic niche
(Mirzadeh et al., 2008; Shen et al., 2008; Tavazoie et al.,
2008). A specialized vasculature with reduced pericyte
coverage is an integral part of the SVZ neurogenic niche
(Tavazoie et al., 2008). When stem cells in the SVZ transi-
tion from the quiescent B cell stage to the proliferative
C-cell stage, they move from a position close to the epen-
dymal cell layer to the underlying vasculature (Kokovay
et al., 2010). As the C-cells develop into migratory neuro-
blasts (A-cells), the vasculature in the SVZ and the rostral
migratory stream (RMS) is used as a migratory scaffold,
guiding the cells toward the olfactory bulbs (Bovetti
et al., 2007). These studies suggest an intimate relation-
ship between SVZ stem and progenitor cells and the
specialized vasculature; however, whether the stem and
progenitor cells can directly influence the surrounding
vasculature is less clear.440 Stem Cell Reports j Vol. 2 j 440–448 j April 8, 2014 j ª2014 The AuthorWe and others have previously studied the effects of
intracerebroventricular (ICV) epidermal growth factor
(EGF) infusion on neural stem and progenitor cells in
the SVZ. Apart from inducing proliferation, EGF infusion
reduces the number of neuroblasts, induces atypical migra-
tion of oligodendrocyte-like progenitors, stimulates ex-
pansion and migration of OLIG2-expressing progenitors
in the rostral migratory stream, and leads to polyp forma-
tion in the rat SVZ (Craig et al., 1996; Kuhn et al., 1997;
Doetsch et al., 2002; Gonzalez-Perez et al., 2009; Lindberg
et al., 2012a, 2012b).
Microglia are the resident immune cells of the brain,
derived from yolk-sac macrophages. Microglia precursors
invade the brain during development before vasculari-
zation occurs (Arnold and Betsholtz, 2013). In addition
to functions in the immune response and tissue ho-
meostasis, microglia modulate SVZ adult neurogenesis
(Walton et al., 2006; Liao et al., 2008). In the retina,
microglia are implicated in vascular development,
angiogenesis, and capillary sprouting (Checchin et al.,
2006; Unoki et al., 2010; Bourghardt Peebo et al.,
2011).
We introduce a reproducible model of inducing angio-
genesis in the adult SVZ by extended ICV infusion of
EGF. Within 14 days of infusion, EGF-induced SVZ
polyps attract blood vessels, a process that is preceded by
microglia/macrophages accumulation and cell death. The
current study suggests an important role of microglia/
macrophages in the induction of brain angiogenesis and
provides a model by which the early stages of angiogenesis
can be readily explored.s
Figure 1. EGF Infusion Induces Polyp Formation and Polyp-Associated Angiogenesis
(A–E) Endothelial cells visualized by RECA-1 (green) and nuclei labeled using TOPRO3 (red) in the vehicle-treated control SVZ (aCSF) (A)
and in EGF-induced polyps SVZ (B–D). Polyps formed after 7 days of EGF infusion were present as convex protrusions from the SVZ (B) or as
slightly larger spherical structures (C). Following 14 days of EGF infusion polyps were larger and persistently displayed blood vessel
recruitment (D) or a complex vascular network in the polyp core (E). Scale bars, 50 mm.
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Development of Epidermal-Growth-Factor-Induced
Polyp Formation Results in Angiogenesis
We have previously described how ICV infusion of EGF
increases proliferation and size of the rat subventricular
zone. Prolonged infusion for 14 days induces the forma-
tion of focal dysplastic polyps (Kuhn et al., 1997; Lind-
berg et al., 2012a). The EGF-induced polyps show distinct
expression of neural stem cell and progenitor markers and
display unique ultrastructural characteristics. In the cur-
rent study, EGF or artificial cerebrospinal fluid (aCSF)
was continuously infused ICV for 7 and 14 days to pro-
gressively study polyp formation. No polyps were found
in any of the groups receiving aCSF only (Figure 1A).
Polyp formation was present in all animals receiving
EGF infusion. An average of 1.9 ± 0.5 polyps per 40 mm
section (n = 4, mean ± SE) was found in the lateral ventri-
cles following 14 days of EGF infusion. Studying polyps
after 7 and 14 days of EGF infusion revealed distinct dif-
ferences in polyp appearance. Overall, polyps formed
over 14 days of EGF infusion were almost three times
larger compared to polyps formed over 7 days (22,120 ±
9,366 mm2 and 63,702 ± 15,094 mm2, respectively, n = 4
for both groups, p = 0.0034, mean ± SE). A subset of
polyps formed convex protrusions from the SVZ showing
a relatively small polyp diameter (50 mm) (Figure 1B).
Other polyps were of a spherical shape, occasionally
only connected to the SVZ via a small ‘‘stem’’ (Figure 1C).
Polyps formed after 14 days of EGF infusion were not only
larger, but persistently contained blood vessels. Some
polyps had a single vessel leading into the core of the
polyp (Figure 1D), whereas others had extensive vasculari-
zation in the polyp core (Figure 1E). The polyp blood
vessels were more heterogeneous with respect to vessel
diameter and morphology than were blood vessels of
the control SVZ (Figure 1E).StemChanges in Microglia/Macrophages and Angiogenesis
Mark Distinct Stages in Polyp Progression
Because of the methodological difficulties in separating
microglia from peripherally recruited macrophages, we
will make no such distinction and use the term microglia/
macrophage or refer to the antigen used to label said popu-
lationof cells.Weused an antibody against IBA1 to labelmi-
croglia/macrophages and in smaller polyps, we observed
IBA1+ cells scattered throughout the polyps at a density
similar to the underlying SVZ (Figure 2A). In other polyps
the distribution of IBA1+ cells was less random, with a
tendency toward accumulating in the core (Figure 2B).
The morphology of IBA1+ cells was of a more activated
phenotype with shorter and thicker cellular processes
compared to IBA1+ cells in smaller polyps (Figure 2B). In an-
imals receiving 14 days of EGF infusion, we found polyps
with significant accumulation of IBA1+ cells, occasionally
with a single vessel leading into the polyp core (Figure 2C).
Themajority of IBA1+ cells in the polyp core had a spherical
cell body indicative of amoeboid microglia/macrophages
(Figure 2C). In highly vascularized polyps, IBA1+ cells were
predominantly located in close association with blood ves-
sels, displaying a more ramified appearance compared to
amoeboid IBA1+cells innonvascularizedpolyps (Figure2D).
Combining polyp appearance, vascularization, and IBA1+
cell morphology, distinct stages in polyp development
became apparent. To facilitate analysis of polyp growth
and vascularization, we defined four stages in polyp devel-
opment (I–IV). At stage I, polyps are beginning to protrude
into theventricular space (Figure 1B), containing IBA1+ cells
with a ramified morphology (Figure 2A). At stage II, the
polyps take on a spherical shape (Figure 1C) and certain
compartmentalization of IBA1+ cells is present (Figure 2B).
Early signs of IBA1+ cell core accumulation are present and
the IBA1+ cell morphology is more activated, with a round
shape and shorter processes (Figure 2B). Seven days of EGF
infusion results only in polyps of stages I and II. FollowingCell Reports j Vol. 2 j 440–448 j April 8, 2014 j ª2014 The Authors 441
Figure 2. IBA1+ Cell Accumulation, Distribution, and Activation in EGF-Induced Polyps
(A) Microglia/macrophages (IBA1) in small polyps are ramified in appearance with numerous long processes (stage I).
(B) In spherical, slightly larger polyps IBA1+ cells adopt a more reactive morphology with a rounded shape and short processes (stage II).
(C) Polyp with extensive IBA1+ cell accumulation and aggregation of amoeboid IBA1+ cells in the polyp core (stage III).
(D) IBA1+ cells of vascularized polyps are predominately not amoeboid and frequently line blood vessels (RECA, in red) (stage IV).
(E) Mean cross-sectional area of polyps stages I–IV (F [3, 20] = 58.47, p < 0.0001).
(F) Density of IBA1-labeled IBA1+ cells in polyps stages I–IV (F [3, 17] = 54.90, p < 0.0001).
(G) IBA1+ cells forming a cage-like structure around angiogenic vessel sprouts. Activated pericytes in angiogenic vessel labeled using NG2.
(H) Percentage of IBA1+ cells coexpressing marker of activation CD68 in polyps stages I–IV (F [3, 12] = 0.6653, p = 0.5893).
(I–L) Representative images of IBA1 and CD68 expression in polyps stages I–IV.
Scale bars, 25 mm (A–D), 15 mm (G), and 50 mm (I–L). In (E), n(I) = 8, n(II) = 6, n(III) = 5, n(IV) = 5. In (F), n(I) = 5, n(II) = 7, n(III) = 3,
n(IV) = 6. In (H), n(I) = 4, n(II) = 3, n(III) = 3, n(IV) = 6. All data are presented as mean ± SEM. *p < 0.05; ***p < 0.001.
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angiogenesis (Figure 1D) and extensive IBA1+ cell core accu-
mulation (Figure 2C) define stage III polyps. The final stage
(IV) is characterized by dense polyp core vascularization
(Figure 1E) and vessel-associated IBA1+ cells (Figure 2D).
Infusion of EGFR (EGF receptor) ligand TGFa (transform-
ing growth factor alpha) has previously been reported
to increase the number of microglia in the SVZ. The
TGFa-induced microglia were almost exclusively bromo-442 Stem Cell Reports j Vol. 2 j 440–448 j April 8, 2014 j ª2014 The Authordeoxyuridine (BrdU) negative, suggesting recruitment of
microglia to the EGFR-stimulated SVZ (de Chevigny et al.,
2008). We injected BrdU three times during the last 24 hr
and analyzed the extent ofmicroglial/macrophage prolifer-
ation in polyps using IBA1 as a microglia/macrophage
marker. Only 2.2% of IBA1+ cells (7/324 cells in five ani-
mals) were displaying BrdU immunoreactivity, indicating
migration of IBA1+ cells into the EGF-stimulated, hyper-
proliferative SVZ, rather than local proliferation.s
Figure 3. Morphological and Ultrastructural Features of Polyp Microglia/Macrophages and Polyp-Associated Cell Death
(A) IBA1+ cells in angiogenic polyps displaying tight cell-cell association and ‘‘string of pearl’’ structure (arrows) (A). yz axis (A0) and yx
(A0 0) projection of confocal image stack acquired in (A), showing IBA1+-labeled microglia/macrophage clusters (boxes).
(B) Transmission electron microscopy micrograph of amoeboid cell with intracellular vesicles (*) and cholesterol crystals (arrows) in polyp.
(C) Cell with an abundance of intracellular vesicles (*).
(D) Density of ApopTag-labeled cells in polyps stages I–IV (F [3, 20] = 15,31, p < 0.0001).
(E–H) Representative images of ApopTag (green) and IBA1 (red) in polyps stages I–IV.
Scale bars, 20 mm (A), 2 mm (B and C), and 50 mm (E–H). In (D), n(I) = 5, n(II) = 9, n(III) = 6, n(IV) = 4. All data are presented as mean ±
SEM. *p < 0.05; ***p < 0.001.
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Macrophage Accumulation
Using the established criteria for polyps staging, we
measured the average cross-sectional area of the polyps at
stages I–IV (Figure 2E). The average area of polyps increased
according to stage designation, with stage III polyps
showing a larger cross-sectional area compared to stage I,
and stage IV polyps having the largest cross-sectional area
compared to all other stages (Figure 2E).
Moreover, from stage I to III the density of IBA1+ cells
increased substantially, being 3-fold higher in stage III
polyps compared to stage I polyps. At stage IV, the density
decreased to one-third compared to stage III, a level
comparable to stage II (Figure 2F). In stage III polyps,
IBA1+ cells were frequently found tightly associated to
vessel sprouts. The IBA1+ cells aggregated in cage-like
structures around the angiogenic vessels, which were
covered by strongly NG2 immunoreactive-activated peri-
cytes (Figure 2G).
Microglia activation is a multistep process based
on functional, morphological, and antigenic features (Ket-Stemtenmann et al., 2011). CD68 is a lipoprotein used as a
marker for late-stage microglial activation. IBA1+/CD68+
cells were found in polyps at all stages (Figures 2I–2L).
No significant differences were found between any
of the stages. The average percentage of CD68-express-
ing IBA1+ cells was between 20%–30% in all groups
(Figure 2H).
Unique Morphological and Ultrastructural Features of
Polyp-Associated Microglia/Macrophages
The increasing accumulation of microglia/macrophages
in the polyp stages, leading to angiogenesis in stage III,
suggests an involvement of microglia/macrophages in the
angiogenic process. By acquiring high-density confocal
z stacks of IBA1-labeled cells, we were able to distinguish
additional morphological features of microglia/macro-
phages in angiogenic polyps. As previously described,
amoeboid microglia/macrophages were frequently found
in stage III polyps. Further analysis revealed large cytosolic
compartments and tight association of amoeboid micro-
glia/macrophages that occasionally formed clusters andCell Reports j Vol. 2 j 440–448 j April 8, 2014 j ª2014 The Authors 443
Figure 4. Summary of Microglia/Macro-
phage Invasion, Cell Death, and Angio-
genesis in EGF-Induced Polyps
During the growth of EGF-induced polyps,
cell death increases and microglia/macro-
phages gradually accumulate in the polyp
core and adopt an amoeboid morphology
(stages I–III). At stage III of polyp devel-
opment, cell death and microglia/macro-
phage accumulation reach their peak, and
the first signs of angiogenesis are present.
As vascularization increases in stage IV
polyps, cell death andmicroglia/macrophage
density declines and polyp size increases
substantially. Microglia/macrophages asso-
ciate closely to newly formed vessels and
adopt a more ramified morphology.
Stem Cell Reports
SVZ Microglia/Macrophage-Associated Angiogenesis‘‘string of pearl’’ structures (Figure 3A). This morphology
suggests a common cytosolic syncytium between several
microglia/macrophages, similar to what is observed in the
development in multinucleated giant cells or cytoplasmic
bridges (Evans et al., 1914; Michaels et al., 1988; Hornik
et al., 2013).
To study microglia/macrophage ultrastructure in angio-
genic and vascularized areas, we utilized transmission elec-
tronmicroscopy.We found cells in the polyp stroma fitting
the criteria of amoeboid microglia/macrophages, with an
abundance of intracellular vesicles and a rounded cell
shape.Moreover, these cells occasionally contained choles-
terol crystals and intracellular vesicles (Figure 3B), suggest-
ing phagocytic activity (Tangirala et al., 1994; Klinkner
et al., 1995). The phagocytic phenotype suggests a phago-
somal and/or lysosomal nature of the intracellular vesicles.
Other cells displayed an ultrastructure that inferred a less-
activated state, which lacked cholesterol crystals, had a
more ramified morphology, and still harbored intracellular
vesicles (Figure 3C).
Progressive Cell Death in Developing Polyps,
Declining after Angiogenesis
The accumulation and phagocytic activity of microglia/
macrophages in the core of the growing polyps could be
a consequence of extensive cell death. We used ApopTag
labeling to quantify cell death in stage I–IV polyps (Fig-
ure 3D). Stage I polyps rarely contained ApopTag+ cells
(Figure 3E). In stage II polyps, ApopTag+ cells were occa-
sionally found in the core of the polyps, in areas of IBA1+
cell accumulation (Figure 3F). The density of ApopTag+
cells increased drastically in stage III polyps, concurrent
with increasing microglia/macrophage accumulation (Fig-
ure 3G). In angiogenic stage IV polyps, prominent cell
death was still evident (Figure 3H), albeit at a lower level,
compared to stage III polyps.444 Stem Cell Reports j Vol. 2 j 440–448 j April 8, 2014 j ª2014 The AuthorDISCUSSION
In the current study we demonstrate how EGF infusion
leads to polyp development, microglia/macrophage accu-
mulation, and cell death resulting in focal angiogenesis
(summarized in Figure 4). Angiogenesis is visible after
14 days of EGF infusion; however, a microglia/macrophage
response is present already after 7 days of infusion, preced-
ing angiogenesis. The microglia/macrophage accumula-
tion is concurrent with substantial cell death in the polyp
core. Moreover, a significant increase in polyp size is
observed when comparing stage III angiogenic polyps to
stage IV vascularized polyps, indicating a requirement of
angiogenesis for excessive polyp growth.
The delayed response of the SVZ vasculature to grow
toward and into the polyps, occurring after more than
7 days of EGF infusion, suggests an indirect mechanism,
such as hypoxia, rather than a direct angiogenic effect of
EGF infusion. In the cerebral cortex, hypoxia-induced
angiogenesis is initiated 7 to 14 days after induction of
hypoxia (Masamoto et al., 2013). The accumulation
of microglia/macrophages and dying cells in the core of
stage III polyps and the subsequent reduction in angio-
genic stage IV polyps further strengthens this notion.
Whether the microglia/macrophages are attracted by
hypoxia-induced signaling or by cell death-related signals
remains to be elucidated. However, in the angiogenic stage
III polyps, microglia/macrophages adopt an amoeboid
morphology, engulf nuclei of dying cells, and display
ultrastructural features, suggesting an active role in scav-
enging dead or dying cells. Microglia and macrophages
occasionally express EGFR, and EGF can stimulate micro-
glia migration, acting as a motility factor (Nolte et al.,
1997; Planas et al., 1998; Lamb et al., 2004; Qu et al.,
2012). However, EGFR expression and chemotactic effects
of EGF on microglia/macrophages in vivo appears to bes
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tion, and atherosclerosis (Lamb et al., 2004; Qu et al.,
2012). This could help explain the local, rather than
general, microglia/macrophage recruitment after EGF/
TGFa infusion, specifically to hyperproliferative areas
with extensive cell death in the SVZ demonstrated here
and by others (de Chevigny et al., 2008). One possible
mechanismbehind themicroglia/macrophage recruitment
could be through production of cytokines like CCL2/MCP-
1, TNFa, or IL-1b bymicroglial cells resident in the growing
polyps in response to local hypoxia, like those previously
described after hypoxia in the neonatal brain (Deng et al.,
2008, 2009). Interestingly, amoeboid microglial cells pro-
duce MCP-1 under hypoxia in vitro and express the
MCP-1 receptor CCR2 in vivo. When MCP-1 was injected
intracerebrally amoeboid microglia cells migrated toward
the injection site (Deng et al., 2009). Furthermore, the
altered morphology of microglia/macrophages and close
association to angiogenic vessels we observe, which occur
in stage IV polyps, could represent a change from an angio-
genesis-promoting to a vessel-stabilizing role of microglia/
macrophages. In the retina, transplanted bone marrow-
derived cells differentiate into microglia and promote
vessel normalization in a HIF1a-dependent manner (Ritter
et al., 2006).
SVZ expansion after EGF treatment is to a large extent
caused by extensive proliferation of dysplastic SOX2/
OLIG2-expressing cells (Lindberg et al., 2012a). This
dysplastic cell type is highly enriched in the polyps and
could be involved in microglia/macrophage accumula-
tion and polyp angiogenesis, via paracrine angiogenic
signaling. For instance, neural stem cells are known to pro-
duce substantial amounts of vascular endothelial growth
factor (VEGF) in vitro (Scha¨nzer et al., 2004). Although
VEGF does not appear to induce further proliferation of
neural stem cells in vitro in the presence of growth factors,
neural stem cell-derived VEGF could induce angiogenesis
through endothelial cell proliferation (Fabel et al., 2003).
The polyps are not only unique in their composition of
cells. They lack an ependymal cell layer and the polyps
are freely exposed tomolecules present in the cerebrospinal
fluid (Lindberg et al., 2012a). This could alter the availabil-
ity of both chemoattractants and angiogenic growth fac-
tors in the polyps.
Adult neural stem cells have been suggested as the cells of
origin of certain brain tumors (Vescovi et al., 2006). Neural
stem cells from animals deficient in p16 (Ink4a) and p19
(Arf) that are retrovirally induced to express constitutively
active EGFR persistently form glioma-like tumors in vivo
(Bachoo et al., 2002). Moreover, overexpression of wild-
type Egfr in white matter glial progenitors keeps cells in
an immature state, induces extensive migration, and leads
to formation of tumor-like white matter hyperplasiasStem(Ivkovic et al., 2008). A small population of stem cell-like
cells has been suggested to exist in brain tumors that are
treatment resistant and capable of generating secondary
tumors (Singh et al., 2004). Much like the supportive
niche of neural stem cells, brain tumors appear tomodulate
the microenvironment to provide conditions promoting
stemness (Calabrese et al., 2007). A study investigating
human glioblastoma multiforme tumor progression and
brain location demonstrated increased risk of multifocal
growth and tumor recurrence in tumors located close to
the SVZ (Lim et al., 2007). The present study indicates
that the SVZ neural stem cell niche can respond to the
extensive hyperproliferation by inducing angiogenesis in
hyperproliferative areas, possibly supported by microglia/
macrophages. Microglia/macrophages in polyps could
play a role similar to tumor-associated macrophages,
known to contribute to angiogenic processes in tumors
(Movahedi et al., 2010; Casazza et al., 2013).
Our results suggest that mechanisms formerly attributed
to tumor cells, such as angiogenesis, can be induced in the
neurogenic niche. This indicates that some differences be-
tween stem cells and tumor cells are context dependent
rather than cell intrinsic. Furthermore, our results demon-
strate the importance of nonneurogenic cell types in the
SVZ niche in the progression of the polyps and their ac-
quired angiogenesis. Whether the observed angiogenesis
is more closely related to physiological or pathological
angiogenesis remains to be elucidated. Nonetheless, the
EGF-infusion model could be useful for increasing our
understanding of the events that precede proliferation-
related angiogenesis in both health and disease.EXPERIMENTAL PROCEDURES
Surgery and Tissue Preparation
All experiments were approved by the Gothenburg Committee
of the Swedish Animal Welfare Agency (application nos. 214-
07 and 145-10). Male Wistar rats (Charles River), 7–8 weeks
old, were used in the study. Animals were housed in a barrier
facility with ad libitum access to food and water with a 12 hr
light/dark cycle. All surgeries were performed under ketamine
(33 mg/ml Ketalar, Pfizer) and xylazine (6.67 mg/ml Rompun,
Bayer Healthcare AG) anesthesia. The animals were divided
into groups receiving either vehicle (aCSF) or EGF (360 ng/day).
EGF or vehicle was administered for 7 or 14 days using osmotic
minipumps (Model 1002; Alzet-Durect) and infusion cannulas
(Brain Infusion Kit 2; Alzet-Durect). The surgeries were per-
formed as previously described (Lindberg et al., 2012a). All ani-
mals received three intraperitoneal injections of 50 mg/kg of
BrdU during the last 24 hr before perfusion. At the end of the
EGF infusion period, animals used for immunofluorescence
were sedated using an overdose of pentobarbital and transcar-
dially perfused with sterile 0.9% NaCl followed by phosphate-
buffered (0.1 M [pH 7.4]) 4% paraformaldehyde (PFA). FollowingCell Reports j Vol. 2 j 440–448 j April 8, 2014 j ª2014 The Authors 445
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SVZ Microglia/Macrophage-Associated Angiogenesisperfusion, brains were removed and postfixed in 4% PFA for
24 hr and prepared for cryosectioning by incubation in phos-
phate-buffered (0.1 M [pH 7.4]) 30% sucrose for at least
3 days. All brains were cryosectioned coronally in 40 mm thick
serial sections using a sliding microtome (Leica Microsystems)
and collected as serial sections (1 in 12 series with 480 mm dis-
tance between sections).
Electron Microscopy
For transmission electron microscopy (TEM), animals were
perfused with 0.9% NaCl, followed by 2% PFA and 0.2% glutaral-
dehyde. The brains were postfixed in 2% PFA and 0.2% glutaralde-
hyde for 2 hr and stored in 1% PFA at 4C. The tissue was sectioned
at a thickness of 50 mm using a Leica VT1000S vibratome (Leica
Microsystems). Tissue was further processed and cut as previously
described (Lindberg et al., 2012a). Sections, 60–70 nm thick, were
imaged using a LEO912AB transmission electron microscope
(Zeiss) equipped with a Megaview III CCD camera (Olympus Soft
Imaging Solutions).
Immunohistochemistry
For fluorescent immunohistochemistry, the sections were washed
in Tris-buffered saline (TBS). Sections used for BrdU immunoflu-
orescence were treated with 2M HCl for 30 min at 37C, followed
by neutralization in 0.1 M borate buffer. All sections were
blocked for 1 hr in TBS with 3% donkey serum and 0.1%
Triton-X at room temperature, prior to primary antibody incuba-
tion. The following primary antibodies were used: mouse a-rat
endothelial cell antigen-1 (RECA-1, 1:300, Monosan), goat
a-IBA1 (1:1,000, Abcam), rabbit a-IBA1 (1:1,000, Wako), mouse
a-rat CD68 (1:1,000, Millipore), rat a-BrdU (1:500, Serotech),
and rabbit a-NG2 (1:500, Millipore). Primary antibody incuba-
tion was performed at 4C for 24–72 hr, followed by washing
in TBS. Secondary antibody incubation was performed at room
temperature for 2 hr. The following secondary antibodies were
used: donkey (dk) a-rabbit IgG CF555, dk a-goat IgG CF555, dk
a-goat IgG CF633, dk a-mouse IgG CF488 (Biotium), dk a-rabbit
Alexa 488, dk a-goat Alexa 488, and dk a-rat Alexa 488 (Molecu-
lar Probes). TOPRO3 was used as nuclear stain (Molecular
Probes). After secondary antibody incubation, the sections were
washed in TBS and mounted using ProLong Gold with DAPI
(Molecular Probes).
Cell Death
For analysis of cell death, ApopTag Fluorescein Direct in situ
apoptosis detection kit (Millipore) was used. Sections were
mounted on Superfrost Plus microscope slides (Thermo Scientific)
and dehydrated in increasing concentrations of ethanol (70–99,
5%), followed by a quick submersion in xylene, rehydration,
and wash in TBS. Subsequently, the sections were postfixed in
70% ethanol and acetic acid mixed 2:1 at 20C for 5 min. To
allow proper designation of polyp stage, microglial cells and
macrophages were labeled using an Rb a-IBA1 primary antibody
(Wako). Following 30min of blocking, the sections were incubated
with the primary antibody for 30 min at 37C. After washing
in TBS sections were incubated with a dk a-rabbit Alexa 555
secondary antibody and TOPRO3 nuclear dye for 30 min at446 Stem Cell Reports j Vol. 2 j 440–448 j April 8, 2014 j ª2014 The Author37C, followed by washing. Dying cells were labeled in accordance
with the manufacturer’s instructions.Confocal Microscopy and Quantification
Immunofluorescence was visualized using a Leica SP2 (Leica
Microsystems) and a Zeiss LSM 710 (Carl Zeiss) inverted confocal
microscope. The image stacks were processed in ImageJ (http://
rsbweb.nih.gov/ij/) and arranged in Adobe Photoshop CS5 and
Adobe Illustrator CS5 (Adobe Systems). When studying double
labeling, image stacks were acquired at 0.5 mm increments, and
orthogonal views were used to determine colocalization and
double labeling in single cells. Images used for quantification of
polyp size, IBA1+ cell density, and IBA1/CD68 coexpression, and
ApopTag labeling was quantified in ImageJ using the LOCI plugin.Statistics
All statistical analysis was performed in Prism 6 (Graphpad Soft-
ware). Means in polyp size comparing 7 and 14 days are presented
with standard deviation and compared using a two-tailed Student’s
t test. For statistical analysis comparing more than two groups, a
one-way ANOVA was used, in conjunction with Tukey’s post-hoc
test and presented as means ± SEM. Differences in means resulting
in values of p < 0.05 were considered statistically significant.
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